This compound is a halogenated heterocyclic pharmaceutical intermediate, characterized by a fused cyclooctane ring system and pyridine core. It is primarily utilized in research and manufacturing settings for the synthesis of active pharmaceutical ingredients.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
1-(2-Bromoethoxy)-4-nitrobenzene
pharmaceutical intermediate
Ne-Boc-L-lysine tert-butyl ester hydrochloride
pharmaceutical intermediate
(S)-3-[(Methylsulfonyl)oxy]pyrrolidine-1-carboxylic acid tert-butyl ester
pharmaceutical intermediate
(R)-1-Boc-3-cyanopyrrolidine
pharmaceutical intermediate
2-chloro-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta[b]pyridine
PWYYKWZKLRXRSM-UHFFFAOYSA-N
C1CCCC2=C(CC1)C(=CC(=N2)Cl)C3=CC=C(C=C3)F
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.